Next Article in Journal
Deep Structural Analysis of Myriads of Omicron Sub-Variants Revealed Hotspot for Vaccine Escape Immunity
Next Article in Special Issue
Serological Response to SARS-CoV-2 after COVID-19 Vaccination in Lung Cancer Patients: Short Review
Previous Article in Journal
CVAPPS: A Cross-Sectional Study of SARS-CoV-2 Vaccine Acceptance, Perceptions, and Post-Vaccination Side Effects among Rheumatic Disease Patients in Kuwait
Previous Article in Special Issue
Evolution and Progress of mRNA Vaccines in the Treatment of Melanoma: Future Prospects
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

The Impact of COVID-19 on Pediatric Malignancy Diagnosis and Treatment: Never the Same but Lessons Learned

by
Ghadir K. Katato
1,2,†,
Prasiksha Sitaula
1,2,†,
Avanti Gupte
1,2,3 and
Eman T. Al-Antary
1,2,3,*
1
Division of Hematology/Oncology, Children’s Hospital of Michigan, Detroit, MI 48201, USA
2
Department of Pediatrics, Central Michigan University College of Medicine, Mt Clemons, MI 48603, USA
3
Pediatric Blood and Marrow Transplantation Program, Division of Hematology/Oncology, Barbara Ann Karmanos Cancer Center, Children’s Hospital of Michigan, Detroit, MI 48201, USA
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Vaccines 2023, 11(3), 667; https://doi.org/10.3390/vaccines11030667
Submission received: 25 January 2023 / Revised: 7 March 2023 / Accepted: 8 March 2023 / Published: 15 March 2023
(This article belongs to the Special Issue Oncology in the Era of SARS-CoV-2)

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic affected the pediatric oncology population globally. Over the course of 2 years, increasing reports have been made to better understand this entity and its pathologic complications on these patients. The pandemic has allowed healthcare providers, hospital systems, and leading oncologic societies to quickly adapt and formulate new guidelines for the effective understanding, management, and treatment of patients with pediatric malignancy.
Keywords: COVID-19; oncology; pediatric; epidemiology; management; diagnosis COVID-19; oncology; pediatric; epidemiology; management; diagnosis

Share and Cite

MDPI and ACS Style

Katato, G.K.; Sitaula, P.; Gupte, A.; Al-Antary, E.T. The Impact of COVID-19 on Pediatric Malignancy Diagnosis and Treatment: Never the Same but Lessons Learned. Vaccines 2023, 11, 667. https://doi.org/10.3390/vaccines11030667

AMA Style

Katato GK, Sitaula P, Gupte A, Al-Antary ET. The Impact of COVID-19 on Pediatric Malignancy Diagnosis and Treatment: Never the Same but Lessons Learned. Vaccines. 2023; 11(3):667. https://doi.org/10.3390/vaccines11030667

Chicago/Turabian Style

Katato, Ghadir K., Prasiksha Sitaula, Avanti Gupte, and Eman T. Al-Antary. 2023. "The Impact of COVID-19 on Pediatric Malignancy Diagnosis and Treatment: Never the Same but Lessons Learned" Vaccines 11, no. 3: 667. https://doi.org/10.3390/vaccines11030667

APA Style

Katato, G. K., Sitaula, P., Gupte, A., & Al-Antary, E. T. (2023). The Impact of COVID-19 on Pediatric Malignancy Diagnosis and Treatment: Never the Same but Lessons Learned. Vaccines, 11(3), 667. https://doi.org/10.3390/vaccines11030667

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop